MS Drug May Increase Risk Of Macular Edema In Patients With Diabetes, Uveitis

by OphthalmologyWeb • 2011/03/14 • 0 Comments

A newly approved multiple sclerosis drug poses a potential risk of macular edema in patients with diabetes mellitus and a history of uveitis, a speaker said here.

Full Story →

← Merck Announces FDA Acceptance Of New Drug Application For Investigational Ophthalmic Medication SAFLUTAN(R) (Tafluprost)

Vision Care In The Workplace →

Post navigation